Lucy Payton 
Modern medicine increasingly relies on advanced diagnostics, which allow us not only to see but also to understand the processes taking place in the human body at the cellular level. One of the most dynamically developing areas is molecular imaging – a technology that allows the biological functions of tissues and organs to be assessed with unprecedented precision.
At the forefront of this revolution is United Imaging Healthcare (UIH), a global leader in innovative diagnostic systems that is consistently pushing the boundaries of modern radiology.
Molecular imaging – the future of personalized medicine
Traditional imaging tests, such as computed tomography (CT) and magnetic resonance imaging (MRI), focus on the anatomical structure of the body. Molecular imaging goes a step further—it allows for the analysis of metabolic, biochemical, and molecular processes that accompany diseases in their earliest stages. This makes it possible to detect pathological changes before they become anatomically visible, which is of great importance in oncology, neurology, and cardiology.
For years, UIH has been developing technologies that combine the capabilities of structural and molecular imaging to create next-generation PET/CT and PET/MR systems. These innovations significantly improve the quality of diagnostics, shorten examination times, and increase precision—all with patient comfort and physician efficiency in mind.
uEXPLORER® – a breakthrough in whole-body diagnostics
One of United Imaging Healthcare’s most impressive achievements is uEXPLORER® – the world’s first PET/CT system capable of real-time whole-body imaging. This device has been designed for maximum sensitivity and efficiency. It offers an axial field of view of up to 194 cm, allowing the entire body of the patient to be scanned in a single position, without the need to move the table repeatedly.
The use of modern detectors and image reconstruction algorithms means that uEXPLORER® provides extremely detailed data on the metabolic processes taking place in the body. The examination takes only a few dozen seconds, and the quality of the images obtained allows even micro-focal cancerous lesions or inflammatory changes to be detected in the early stages of the disease. It is thanks to such technologies that the idea of precision medicine, based on early detection and an individual approach to the patient, becomes possible.
uMI Panorama and uMI Vista – intelligent systems of the new generation
UIH is constantly developing its offering in the field of molecular imaging. The latest breakthrough solutions are uMI Panorama and uMI Vista – advanced digital PET/CT systems that combine exceptional sensitivity with excellent spatial resolution.
Thanks to the use of silicon photomultipliers (SiPM) and fiber optic data transmission, these devices provide images of exceptional clarity while minimizing radiation dose.
The uMI Panorama system offers the highest temporal and spatial resolution in the industry, allowing even the smallest metabolic changes to be observed. Combined with AI-Assisted Workflow technology, the device automatically optimizes examination parameters and patient positioning, reducing preparation time and increasing diagnostic accuracy.
The uMI Vista, on the other hand, is an example of a system that combines imaging precision with versatility of application—from oncology to neurology and cardiology.
AI in the service of diagnostics—intelligent analysis and automation
Artificial intelligence is an integral part of UIH’s development philosophy. PET/CT and PET/MR systems use machine learning solutions that analyze images in real time, automatically detecting potential abnormalities. This provides physicians with not only raw data, but also a pre-processed analysis that supports the diagnostic process.
The use of AI in molecular imaging also increases the efficiency of diagnostic centers. The automation of image reconstruction, segmentation, and archiving processes reduces examination time and increases the number of patients served without compromising quality. As a result, facilities gain greater throughput and profitability, and patients gain faster access to results.
Sustainable development and global availability of technology
UIH combines technological excellence with social responsibility. The company actively works to democratize access to modern diagnostics, delivering its solutions to over 75 countries worldwide.
The technologies it implements are designed with energy efficiency, reduced consumables, and maximum component durability in mind. In this way, UIH pursues the idea of sustainable development in medicine—providing equipment that not only saves lives but also protects the environment.
The future that is happening today
Molecular imaging is the future of diagnostics, and it is already changing modern medicine. With solutions such as uEXPLORER®, uMI Vista, and uMI Panorama, United Imaging Healthcare enables physicians to diagnose, plan treatment, and monitor its effects with unprecedented accuracy.
The innovations introduced by UIH are not just about technology—they represent a new way of thinking about health and the role of diagnostics in a patient’s life. Through its commitment to research, collaboration with scientific centers, and implementation of intelligent solutions, UIH proves that the future of medicine is already here, and at its heart is advanced, precise, and accessible molecular imaging.
